Radiation sickness syndrome and drugs of ingredients of diatrizoate meglumine; diatrizoate sodium - a phase IV clinical study of FDA data
There is no Radiation sickness syndrome reported by people who take drugs with ingredients of diatrizoate meglumine; diatrizoate sodium yet. This review analyzes which people have Radiation sickness syndrome with drugs with ingredients of diatrizoate meglumine; diatrizoate sodium. It is created by eHealthMe based on reports from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Angiovist 292, Angiovist 370, Diatrizoate meglumine and diatrizoate sodium, Diatrizoate-60, Gastrografin, Gastrovist, Hypaque-76, Hypaque-m,75%, Hypaque-m,90%, Md-60, Md-76, Md-76r, Md-gastroview, Renocal-76, Renografin-60, Renografin-76, Renovist, Renovist ii.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of diatrizoate meglumine; diatrizoate sodium, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amlodipine Besylate and Betoptic drug interaction - a second ago
- Ovral and Prandin drug interaction - 15 seconds ago
- Vraylar and Mood Swings - 23 seconds ago
- How effective is Viibryd for Depressed Mood? - 25 seconds ago
- 5 Htp vs. Haldol - 29 seconds ago
- Neulasta and Vitamins drug interaction - 30 seconds ago
- Cymbalta and Pityriasis Rosea - 42 seconds ago
- Focalin Xr and Aciphex drug interaction - 47 seconds ago
- Delayed Ejaculation in Anastrozole, how severe and when it was recovered? - 52 seconds ago
- Lipitor and Blood Carbon Dioxide Increased - a minute ago